Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Adalimumab improved folliculitis decalvans in most patients.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

JAK inhibitors are effective for long-term management of alopecia areata.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Newly made nicotinamide compounds could potentially treat cancer.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

JAK inhibitors are effective and safe for treating severe alopecia areata.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.